Flow Diagram RWISA longitudinal insulin resistance study; RWISA, Rwanda Women’s Interassociation Study Assessment; HIV, Human immunodeficiency virus; ART, antiretroviral therapy; HIV+, HIV-infected; HIV-, HIV-uninfected.

<p>Flow Diagram RWISA longitudinal insulin resistance study; RWISA, Rwanda Women’s Interassociation Study Assessment; HIV, Human immunodeficiency virus; ART, antiretroviral therapy; HIV+, HIV-infected; HIV-, HIV-uninfected.</p

Description of ART usage among 371 women who initiated treatment.

<p>Proportions of HIV+ ART initiators: 26.7% used AZT, 62.5% used D4T, 89.1% used NRTI total and 1.3% used NRTI other than AZT or D4T.</p><p>Description of ART usage among 371 women who initiated treatment.</p